Drug-Eluting Balloons-A New Tool in the Treatment of Cardiac Allograft Vasculopathy: A Case Series

Transplant Proc. 2017 Sep;49(7):1675-1677. doi: 10.1016/j.transproceed.2017.06.010.

Abstract

Percutaneous coronary intervention in patients with cardiac allograft vasculopathy is burdened with a lot of difficulties. Although they have allowed significant progress in comparison with plain balloon angioplasty and bare metal stents, drug-eluting stents have not fully overcome problems of diffuse lesions and small-vessel disease that are so common in transplant coronary artery disease. There is growing evidence that drug-eluting balloons might be a better choice for patients with small vessel atherosclerotic coronary disease and yet there is no experience with this technology in patients with cardiac allograft vasculopathy. Herein we report a case series of successful percutaneous coronary interventions in patients with cardiac allograft vasculopathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angioplasty, Balloon, Coronary / methods*
  • Coronary Artery Disease / etiology
  • Coronary Artery Disease / surgery*
  • Female
  • Heart Transplantation / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / methods*
  • Postoperative Complications / etiology
  • Postoperative Complications / surgery*
  • Treatment Outcome